Seelos Therapeutics Inc (SEEL)
1.06
+0.14
(+15.22%)
USD |
OTCM |
Nov 05, 09:53
Seelos Therapeutics Net Income (Annual): -37.88M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -37.88M |
December 31, 2022 | -73.53M |
December 31, 2021 | -66.05M |
December 31, 2020 | -19.10M |
December 31, 2019 | -51.26M |
December 31, 2018 | -9.242M |
December 31, 2017 | 0.321M |
December 31, 2016 | -7.433M |
December 31, 2015 | -19.02M |
December 31, 2014 | -21.79M |
December 31, 2013 | -16.94M |
December 31, 2012 | -31.77M |
December 31, 2011 | -18.12M |
December 31, 2010 | -29.51M |
Date | Value |
---|---|
December 31, 2009 | -32.04M |
December 31, 2008 | -5.171M |
December 31, 2007 | -8.787M |
December 31, 2006 | -8.043M |
December 31, 2005 | -15.44M |
December 31, 2004 | -17.02M |
December 31, 2003 | -17.23M |
December 31, 2002 | -27.64M |
December 31, 2001 | -16.17M |
December 31, 2000 | -8.830M |
December 31, 1999 | -2.507M |
December 31, 1998 | -4.779M |
December 31, 1997 | -3.858M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-73.53M
Minimum
2022
-19.10M
Maximum
2020
-49.56M
Average
-51.26M
Median
2019
Net Income (Annual) Benchmarks
180 Life Sciences Corp | -19.94M |
Cassava Sciences Inc | -97.22M |
Cara Therapeutics Inc | -118.51M |
Citius Pharmaceuticals Inc | -32.54M |
Moleculin Biotech Inc | -29.77M |